Sort
85,873 grants matching “alzheimers”
The Role of Intracranial Atherosclerosis in the Development of Alzheimer's Disease
$1,694,674Bruce A Wasserman · Johns Hopkins University · R01 · FY2017 · AG
Examination of neural circuits underlying mood disorders in Alzheimer?s disease
$1,694,505Li-Huei Tsai · Massachusetts Institute Of Technology · RF1 · FY2014 · AG
Epidemiology of Brain Aging in the Very Old
$1,694,435Kuakini Medical Center · U01 · FY2004 · AG
The Mexican Health Aging Study (MHAS)
$1,694,384Rebeca Wong · University Of Texas Hlth Science Center · R01 · FY2024 · AG
Presenilin Biology and the Mechanisms of Alzheimer's Disease
$1,694,365Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2023 · AG
Pathway discovery, validation and compound identification for Alzheimer's disease
$1,694,201Philip L De Jager · Broad Institute, Inc. · U01 · FY2013 · AG
Longitudinal Neurometabolic Outcomes of Traumatic Stress-Related Accelerated Cellular Aging
$1,694,033Erika J Wolf · Boston University Medical Campus · RF1 · FY2020 · AG
Alzheimer's Disease Research Center
$1,694,021Mary Sano · Icahn School Of Medicine At Mount Sinai · P50 · FY2008 · AG
HEALTHY AGING AND SENILE DEMENTIA
$1,693,827Washington University · P01 · FY2000 · AG
Presenilin Biology and the Mechanisms of Alzheimer's Disease
$1,693,685Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2021 · AG
Presenilin Biology and the Mechanisms of Alzheimer's Disease
$1,693,684Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2022 · AG
Center for Alzheimer's and Related Dementias (CARD): Collaboration with the Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat)
$1,693,659Mark Cookson · National Institute On Aging · ZIA · FY2025 · AG
Down Syndrome: a potential treatment XISTs
$1,693,316Volney L Sheen · Beth Israel Deaconess Medical Center · R01 · FY2022 · HD
Spatial-Temporal Characterization of The Hemodynamic Response to Neural Activity
$1,693,292Afonso Silva · National Institute Of Neurological Disorders And Stroke · ZIA · FY2019 · NS
Evaluation of a dual PPAR agonist for treatment of Alzheimer's disease
$1,692,440James Cardelli · Oleolive, Inc. · R42 · FY2022 · AG
Presenilin Biology and the Mechanisms of Alzheimer's Disease
$1,692,325Dennis J Selkoe · Brigham And Women'S Hospital · P01 · FY2020 · AG
Admin Core
$1,692,309Lindsay A. Farrer · Boston University Medical Campus · U19 · FY2023 · AG
HEALTHY AGING AND SENILE DEMENTIA
$1,691,795John Morris · Washington University · P01 · FY2013 · AG
Repurposing FDA-approved agonists of HCAR2 as novel therapeutics for Alzheimer's Disease
$1,691,548Gary E. Landreth · Indiana University Indianapolis · RF1 · FY2022 · AG
Protective roles of grape-derived polyphenols in Alzheimer's disease
$1,691,330Giulio Maria Pasinetti · Icahn School Of Medicine At Mount Sinai · P01 · FY2007 · AT
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease
$1,691,295Bin Zhang · Icahn School Of Medicine At Mount Sinai · U01 · FY2019 · AG
Alzheimer's Disease Prevention Trial with Estrogens
$1,690,981Mary Sano · Icahn School Of Medicine At Mount Sinai · R01 · FY2007 · AG
Health of the Cholinergic System and Risk for Alzheimer's Disease in Postmenopausal Women
$1,690,482Julie A Dumas · University Of Vermont & St Agric College · R01 · FY2023 · AG
Bioinformatics
$1,690,437Leping Li · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
Vanderbilt Alzheimer's Disease Research Center
$1,689,678Angela L. Jefferson · Vanderbilt University Medical Center · P20 · FY2022 · AG